Impact of Caregiver Depression on Asthma in the Child
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00223288|
Recruitment Status : Completed
First Posted : September 22, 2005
Last Update Posted : August 3, 2011
This study will examine if depression in a primary caregiver is associated with more hospitalization or ER visits in children with asthma. This study will also explore whether treatment for depression in the primary caregivers is associated with improvement in asthma in school-aged children.
Asthma is a very common childhood disorder of airway inflammation. The causes include environmental irritants, cold temperature, and infection in the respiratory tract, and emotional factors can contribute to symptom exacerbation. However, asthma is a disease that can be well controlled if there is proper medication compliance and careful control of environmental conditions.
Data suggests that psychiatric symptoms in the mothers of children with asthma are associated with more asthma related hospitalizations in children. Thus, we want to explore this question further using more specific diagnostic instruments in order to detect what types of symptoms are associated with increased asthma related service utilization. Also, we want to explore if effective treatment of the caregivers' symptoms is associated with decreased hospitalization and emergency room visits for the child.
|Condition or disease||Intervention/treatment|
|Depressive Disorder, Major Asthma||Drug: Lexapro|
|Study Type :||Observational|
|Enrollment :||175 participants|
|Official Title:||Caregiver Psychiatric Symptomatology and it's Relationship to Service Utilization by Children With Asthma|
|Study Start Date :||March 2003|
|Actual Primary Completion Date :||February 2006|
|Actual Study Completion Date :||February 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00223288
|United States, Texas|
|The University of Texas Southwestern Medical Center at Dallas|
|Dallas, Texas, United States, 75235|
|Principal Investigator:||E. Sherwood Brown, MD, Ph.D.||University of Texas, Southwestern Medical Center at Dallas|